Feasibility of Immunohistochemical p16 Staining in the Diagnosis of Human Papillomavirus Infection in Patients With Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta-Analysis.

human papillomavirus immunohistochemical staining meta-analysis p16 squamous cell cancers of the head and neck

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 07 01 2020
accepted: 10 09 2020
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 17 12 2020
Statut: epublish

Résumé

Human papillomavirus (HPV) is a risk factor for squamous cell carcinoma of the head and neck (HNSCC). This study aimed to investigate the feasibility of IHC- p16INK4a (p16) as an alternative modality for diagnosing HPV infection. We searched PubMed, EMBASE, Web of Science, and Cochrane library for studies that evaluated the diagnostic accuracy of IHC-p16 staining. A total of 30 studies involving 2,963 patients were included from 2007 to 2019. The combined sensitivity was 0.94 (95% CI: 0.92-0.95); specificity, 0.90 (95% CI: 0.89-0.91); positive likelihood ratio (LR), 6.80 (95% CI: 5.63-8.21); negative LR, 0.10 (95% CI: 0.07-0.16); diagnostic odds ratio, 85.98 (95% CI: 55.57-133.03); and area under the curve value, 0.9550. Subgroup analysis showed that the IHC-p16 test was more consistent with the

Identifiants

pubmed: 33324540
doi: 10.3389/fonc.2020.524928
pmc: PMC7724109
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

524928

Informations de copyright

Copyright © 2020 Wang, Zhang, Bai, Wang, Wei, Ji, Xin, Dong and Jiang.

Références

Radiother Oncol. 2013 May;107(2):242-6
pubmed: 23602369
Am J Surg Pathol. 2012 Jul;36(7):945-54
pubmed: 22743284
Braz J Med Biol Res. 2013 Mar;46(3):217-26
pubmed: 23532264
Virchows Arch. 2015 Oct;467(4):405-15
pubmed: 26229021
Head Neck Pathol. 2014 Jun;8(2):157-63
pubmed: 24271958
Head Neck Pathol. 2009 Mar;3(1):78-81
pubmed: 20596995
Br J Cancer. 2013 Mar 19;108(5):1157-62
pubmed: 23403821
J Clin Pathol. 2003 Jan;56(1):56-63
pubmed: 12499437
Patholog Res Int. 2011;2011:138469
pubmed: 21772959
Oral Oncol. 2013 Jan;49(1):1-8
pubmed: 22841678
Oral Oncol. 2013 Oct;49(10):e33-7
pubmed: 23962789
Virchows Arch. 2013 Apr;462(4):381-9
pubmed: 23503925
Head Neck Pathol. 2012 Jul;6 Suppl 1:S63-74
pubmed: 22782225
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Int J Cancer. 2013 Feb 15;132(4):882-90
pubmed: 22821242
Oral Oncol. 2014 Apr;50(4):306-10
pubmed: 24485566
Int J Cancer. 2011 Jul 1;129(1):101-10
pubmed: 21190188
Acta Otolaryngol. 2017 Oct;137(10):1121-1126
pubmed: 28669249
J Clin Pathol. 2011 Apr;64(4):308-12
pubmed: 21345874
J Clin Oncol. 2006 Feb 10;24(5):736-47
pubmed: 16401683
Oral Oncol. 2016 Nov;62:101-108
pubmed: 27865361
Int J Cancer. 2010 Oct 1;127(7):1595-602
pubmed: 20091864
J Clin Virol. 2011 Jun;51(2):100-4
pubmed: 21527208
JAMA. 2018 Jan 23;319(4):388-396
pubmed: 29362800
Am J Surg Pathol. 2017 Dec;41(12):1722-1728
pubmed: 28877058
Int J Oncol. 2014 Jul;45(1):67-76
pubmed: 24820457
Oral Oncol. 2014 May;50(5):370-9
pubmed: 24331868
J Clin Oncol. 2013 Feb 10;31(5):543-50
pubmed: 23295795
Am J Surg Pathol. 2012 Dec;36(12):1874-82
pubmed: 23060353
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Eur J Cancer. 2009 Nov;45(17):2935-9
pubmed: 19766476
Cancer Cytopathol. 2015 Dec;123(12):723-31
pubmed: 26242494
J Natl Cancer Inst. 2016 Jan 28;108(6):djv403
pubmed: 26823521
Am J Surg Pathol. 2013 Sep;37(9):1349-56
pubmed: 23797720
Ann Oncol. 2018 May 1;29(5):1273-1279
pubmed: 29438466
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
Int J Cancer. 2010 Apr 15;126(8):1882-1894
pubmed: 19795456
Oral Oncol. 2016 Oct;61:55-61
pubmed: 27688105
Head Neck. 2014 May;36(5):750-9
pubmed: 23606404
Cell. 1999 Apr 2;97(1):53-61
pubmed: 10199402
Int J Cancer. 2007 Dec 1;121(11):2465-72
pubmed: 17680565
Papillomavirus Res. 2018 Dec;6:58-62
pubmed: 30391364
Oncotarget. 2014 Jun 30;5(12):3956-69
pubmed: 24970795
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Am J Surg Pathol. 2011 Sep;35(9):1343-50
pubmed: 21836494
Cancer Res. 2012 Oct 1;72(19):4993-5003
pubmed: 22991302
Lancet Oncol. 2010 Aug;11(8):781-9
pubmed: 20451455
JAMA. 2012 Feb 15;307(7):693-703
pubmed: 22282321
Am J Pathol. 2003 Mar;162(3):747-53
pubmed: 12598309
Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):160-164
pubmed: 28777152
J Clin Oncol. 2008 Jul 1;26(19):3128-37
pubmed: 18474878
Cancer. 2001 Aug 15;92(4):805-13
pubmed: 11550151
Hum Pathol. 2019 Aug;90:97-105
pubmed: 31121191
Lancet Oncol. 2017 Jun;18(6):704-705
pubmed: 28434659
Ann Oncol. 2013 Nov;24(11):2740-5
pubmed: 23946330
Clin Cancer Res. 2005 Aug 15;11(16):5694-9
pubmed: 16115905
Oral Oncol. 2010 Jul;46(7):492-6
pubmed: 20227331
Hum Pathol. 2018 Aug;78:63-71
pubmed: 29684499
Am J Surg Pathol. 2015 Dec;39(12):1643-52
pubmed: 26426378
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
J Clin Oncol. 2009 Apr 20;27(12):1992-8
pubmed: 19289615
Head Neck Pathol. 2012 Jul;6 Suppl 1:S75-82
pubmed: 22782226
Int J Cancer. 2017 Mar 1;140(5):1186-1198
pubmed: 27859245
Lancet Oncol. 2017 Jun;18(6):803-811
pubmed: 28434660
Int J Cancer. 2014 Nov 15;135(10):2404-12
pubmed: 24706381
J Clin Oncol. 2015 Oct 10;33(29):3227-34
pubmed: 26351353
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Nov;122(5):609-618.e7
pubmed: 27765330
Hum Pathol. 2015 May;46(5):681-9
pubmed: 25708613
Clin Cancer Res. 2011 Oct 1;17(19):6262-71
pubmed: 21969383
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Br J Cancer. 2015 Mar 17;112(6):1098-104
pubmed: 25688737
Papillomavirus Res. 2018 Dec;6:1-5
pubmed: 29842928
J Clin Oncol. 2009 Dec 20;27(36):6213-21
pubmed: 19884544
Mod Pathol. 2015 Dec;28(12):1518-27
pubmed: 26403782

Auteurs

Huanhuan Wang (H)

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Yuyu Zhang (Y)

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Wei Bai (W)

Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.

Bin Wang (B)

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Jinlong Wei (J)

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Rui Ji (R)

Department of Biology, Valencia College, Orlando, FL, United States.

Ying Xin (Y)

Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China.

Lihua Dong (L)

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Xin Jiang (X)

Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Classifications MeSH